$666.30 Million in Sales Expected for Stericycle, Inc. (NASDAQ:SRCL) This Quarter

Wall Street brokerages expect Stericycle, Inc. (NASDAQ:SRCLGet Rating) to post $666.30 million in sales for the current fiscal quarter, Zacks reports. Two analysts have made estimates for Stericycle’s earnings, with the highest sales estimate coming in at $667.20 million and the lowest estimate coming in at $665.40 million. Stericycle reported sales of $668.00 million in the same quarter last year, which indicates a negative year-over-year growth rate of 0.3%. The company is scheduled to report its next earnings report on Monday, January 1st.

According to Zacks, analysts expect that Stericycle will report full-year sales of $2.71 billion for the current financial year, with estimates ranging from $2.68 billion to $2.73 billion. For the next fiscal year, analysts expect that the business will post sales of $2.83 billion, with estimates ranging from $2.83 billion to $2.84 billion. Zacks’ sales averages are an average based on a survey of research firms that follow Stericycle.

Stericycle (NASDAQ:SRCLGet Rating) last issued its quarterly earnings data on Thursday, February 24th. The business services provider reported $0.38 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.44 by ($0.06). Stericycle had a positive return on equity of 8.26% and a negative net margin of 1.05%. The business had revenue of $657.30 million for the quarter, compared to analysts’ expectations of $662.25 million. During the same period last year, the business earned $0.59 earnings per share. The company’s revenue for the quarter was up .2% on a year-over-year basis.

Several research firms have commented on SRCL. StockNews.com raised shares of Stericycle from a “hold” rating to a “buy” rating in a research note on Wednesday. Robert W. Baird lowered their target price on shares of Stericycle from $77.00 to $72.00 and set an “outperform” rating for the company in a research note on Friday, February 25th. Finally, Zacks Investment Research cut shares of Stericycle from a “hold” rating to a “sell” rating and set a $62.00 target price for the company. in a research note on Tuesday, March 1st. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $67.00.

SRCL stock opened at $55.38 on Wednesday. The stock has a market capitalization of $5.09 billion, a P/E ratio of -178.64, a PEG ratio of 3.16 and a beta of 1.30. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.79 and a current ratio of 0.79. Stericycle has a one year low of $53.25 and a one year high of $79.97. The company has a 50 day moving average price of $57.48 and a two-hundred day moving average price of $60.15.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Seelaus Asset Management LLC purchased a new stake in shares of Stericycle during the 1st quarter valued at $798,000. Roberts Wealth Advisors LLC lifted its holdings in shares of Stericycle by 7.6% during the 1st quarter. Roberts Wealth Advisors LLC now owns 27,077 shares of the business services provider’s stock valued at $1,596,000 after acquiring an additional 1,910 shares in the last quarter. Norges Bank acquired a new position in shares of Stericycle during the 4th quarter valued at $46,372,000. Quent Capital LLC acquired a new position in shares of Stericycle during the 4th quarter valued at $33,000. Finally, BlackRock Inc. lifted its holdings in shares of Stericycle by 3.0% during the 4th quarter. BlackRock Inc. now owns 7,509,934 shares of the business services provider’s stock valued at $447,892,000 after acquiring an additional 216,364 shares in the last quarter. 97.67% of the stock is owned by institutional investors.

About Stericycle (Get Rating)

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including sharps disposable and management solutions; pharmaceutical waste services; hazardous waste disposal; maritime waste services, such as seaport and airport waste; and compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names.

Recommended Stories

Get a free copy of the Zacks research report on Stericycle (SRCL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.